Changes in regional brain F-18-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure
I. Cranston et al., Changes in regional brain F-18-fluorodeoxyglucose uptake at hypoglycemia in type 1 diabetic men associated with hypoglycemia unawareness and counter-regulatory failure, DIABETES, 50(10), 2001, pp. 2329-2336
We examined the effects of acute moderate hypoglycemia and the condition of
hypoglycemia unawareness on regional brain uptake of the labeled glucose a
nalog [F-18]fluorodeoxyglucose (FDG) using positron emission tomography (PE
T). FDG-PET was performed in diabetic patients with (n = 6) and without (n
= 7) hypoglycemia, awareness. Each patient was studied at plasma glucose le
vels of 5 and 2.6 mmol/l, applied by glucose clamp techniques, in random or
der. Hypoglycemia-unaware patients were asymptomatic during hypoglycemia, w
ith marked attenuation of their epinephrine responses (mean [+/- SD] peak o
f 0.77 +/- 0.39 vs. 7.52 +/- 2.9 nmol/l; P < 0.0003) and a reduced global b
rain FDG uptake ([mean +/- SE] 2.592 +/- 0.188 vs. 2.018 +/- 0.174 at eugly
cemia; P = 0.027). Using statistical parametric mapping (SPM) to analyze im
ages of FDG uptake, we identified a subthalamic brain region that exhibited
significantly different behavior between the aware and unaware groups. In
the aware group, there was little change in the normalized FDG uptake in th
is region in response to hypoglycemia ([mean +/- SE] 0.654 +/- 0.016 to 0.6
36 +/- 0.013; NS); however, in the unaware group, the uptake in this region
fell from 0.715 +/- 0.015 to 0.623 +/- 0.012 (P = 0.001). Our data were co
nsistent with the human hypoglycemia sensor being anatomically located in t
his brain region, and demonstrated for the first time a change in its metab
olic function associated. with the failure to trigger a counter-regulatory
response.